✦ LIBER ✦

Development of a dichloroacetic acid-hemoglobin conjugate as a potential targeted anti-cancer therapeutic

✍ Scribed by Ning Zhang; Andre F. Palmer

Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 612 KB
Volume: 108
Category: Article
ISSN: 0006-3592
DOI: 10.1002/bit.23071

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Tuberculosis Drug Streptomycin as a

The Tuberculosis Drug Streptomycin as a Potential Cancer Therapeutic: Inhibition of miR-21 Function by Directly Targeting Its Precursor

✍ Debojit Bose; Gopal Jayaraj; Hemant Suryawanshi; Prachi Agarwala; Subrata Kumar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 726 KB

ErbB4 increases the proliferation potent

ErbB4 increases the proliferation potential of human lung cancer cells and its blockage can be used as a target for anti-cancer therapy

✍ Alex Starr; Joel Greif; Akiva Vexler; Maia Ashkenazy-Voghera; Valery Gladesh; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 218 KB 👁 1 views

## Abstract Clinical and experimental data suggest that ErbB‐4, a member of the epidermal growth factor receptor family, may have a role in cancer progression and response to treatment. We found recently, using a retrospective clinical analysis, that expression of ErbB‐4 receptor is correlated with

Synthesis and biodistribution studies of

Synthesis and biodistribution studies of iodine-131 D-amino acid YYK peptide as a potential therapeutic agent for labeling an anti-CD20 antibody

✍ K. Sadri; M. Gandomkar; M. H. Babaei; R. Najafi; S. R. Zakavi; S. E. Sadat Ebrah 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 187 KB

## Abstract A major drawback of conventionally radioiodinated monoclonal antibodies for radioimmunotherapy is __in vivo__ dehalogenation of iodine as a result of deiodinase recognition. To solve this problem we have synthesized a YYK tri‐peptide consisting of non‐metabolizable D‐amino acids modifie